HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy.

Abstract
A trial to evaluate the safety and immunogenicity of recombinant modified vaccinia Ankara (MVA) and fowlpox (FP) vectors expressing multiple HIV-1 proteins was conducted in twenty HIV-1 infected youth with suppressed viral replication on HAART. The MVA and FP-based multigene HIV-1 vaccines were safe and well tolerated. Increased frequencies of HIV-1 specific CD4+ proliferative responses and cytokine secreting cells were detected following immunization. Increased frequencies and breadth of HIV-1 specific CD8 T-cell responses were also detected. Plasma HIV-1-specific antibody levels and neutralizing activity were unchanged following vaccination. Poxvirus-based vaccines may merit further study in therapeutic vaccine protocols.
AuthorsThomas C Greenough, Coleen K Cunningham, Petronella Muresan, Margaret McManus, Deborah Persaud, Terry Fenton, Piers Barker, Aditya Gaur, Dennis Panicali, John L Sullivan, Katherine Luzuriaga, Pediatric AIDS Clinical Trials Group P1059 Team
JournalVaccine (Vaccine) Vol. 26 Issue 52 Pg. 6883-93 (Dec 09 2008) ISSN: 0264-410X [Print] Netherlands
PMID18940219 (Publication Type: Clinical Trial, Phase I, Journal Article, Multicenter Study, Research Support, N.I.H., Extramural)
Chemical References
  • AIDS Vaccines
  • Cytokines
  • Gene Products, gag
  • HIV Antibodies
  • RNA, Viral
  • Vaccines, Synthetic
  • Interferon-gamma
Topics
  • AIDS Vaccines (adverse effects, immunology)
  • Adolescent
  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • CD4-CD8 Ratio
  • Cytokines (biosynthesis)
  • Female
  • Flow Cytometry
  • Fowlpox virus (immunology)
  • Gene Products, gag (biosynthesis, genetics)
  • HIV Antibodies (analysis, biosynthesis)
  • HIV Infections (drug therapy, immunology)
  • HIV-1 (genetics, immunology)
  • Humans
  • Interferon-gamma (biosynthesis)
  • Male
  • Prospective Studies
  • RNA, Viral (analysis, biosynthesis)
  • T-Lymphocytes (immunology)
  • Vaccines, Synthetic (immunology)
  • Vaccinia (immunology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: